In Carda Therapeutics, Inc. announced it raised $28 Million in an initial filing from an offering of $50 Million
In Carda Therapeutics, Inc. announced it raised $28 Million in an initial filing from an offering of $50 Million
10/21/20, 5:33 PM
Location
newarkMoney raised
$28 million
Industry
healthcare
Company Info
Location
39899 balentine drive, suite 185
newark, california, united states
Additional Info
InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).